High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801 (Q73825066)
scientific article published on 01 May 2001
Language:
(P31) (Q13442814)
(P304) 2370-2380
(P407) (Q1860)
(P433) 9
(P478) 19
(P577) Tuesday, May 1, 2001
(P921) (Q134808)
(P1433) (Q400292)
(P1476) "High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801" (language: en)
(P2093) J M Kirkwood
J G Ibrahim
J A Sosman
V K Sondak
S S Agarwala
M S Ernstoff
U Rao
other details
description scientific article published on 01 May 2001

External Links